01 1Dasami Lab
01 1CANAGLIFLOZIN (AMORPHOUS)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-02-01
Pay. Date : 2016-09-30
DMF Number : 30972
Submission : 2016-11-18
Status : Active
Type : II
20
Dasami Lab Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CANAGLIFLOZIN (AMORPHOUS), with a corresponding US DMF Number 30972.
Remarkably, this DMF maintains an Active status since its submission on November 18, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 01, 2017, and payment made on September 30, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
